Now I have sufficient calibration data. Let me synthesize the final review.

## Summary

This paper proposes an end-to-end multi-view DR grading framework that eliminates the need for costly external lesion/vessel annotations by self-generating lesion proposals internally. The Grade-Activated Lesion Proposal (GALP) module derives grade-conditioned evidence maps from stage-wise auxiliary classifiers and selects Top-K regions as proposals; the Cross-View Lesion Expert-Guided Regional Fusion (LGRF) module routes these proposals through a gated MoE expert pool and fuses them via Top-K–weighted cross-view attention. Experiments on MFIDDR and DRTiD show the method matches or surpasses several annotation-dependent baselines.

## Strengths

- **Practically important and well-motivated problem.** The paper clearly articulates the clinical burden of requiring external annotations (lesion/vessel masks, OD/macula coordinates) at both training and inference, and the brittleness that arises when auxiliary signals come from separate upstream models. Eliminating this dependency while maintaining end-to-end training is a genuinely valuable goal.

- **Strong empirical results without external supervision.** On MFIDDR, the lesion-free variant achieves 83.9% accuracy, outperforming all end-to-end baselines (best: ETMC at 81.5%) and several externally informed methods (CVSA 82.6%, LFMVDR 82.2%). On DRTiD, the method achieves 76.0% accuracy, surpassing CrossFiT (75.6%) which requires OD/macula coordinates. These are meaningful margins over genuinely distinct categories of methods.

- **Comprehensive experimental coverage.** The paper compares against two broad families of methods (end-to-end and externally-informed), reports multiple metrics (Acc, Spe, Kappa, F1, per-grade F1/AUC), includes ablation studies, hyperparameter analysis, and single-view comparisons. The compatibility with external annotations (84.6% with lesion on MFIDDR) further demonstrates architectural flexibility.

- **Clear and modular architecture.** GALP and LGRF are well-described with coherent mathematical formulations. The ablation (Table 4) shows that removing GALP costs 1.2% Acc, removing LGRF costs 1.6% Acc, and removing experts costs 1.3% Acc, confirming each module contributes non-trivially.

## Weaknesses

### Major:

- **The "lesion proposal" framing is not validated; proposals may not correspond to actual lesions.** The paper's central conceptual claim is that CAM-derived Top-K regions are "lesion proposals" acting as "surrogates for external cues." However, no quantitative evaluation (e.g., IoU, recall, pointing accuracy against the ground-truth lesion masks available in MFIDDR) or even qualitative visualization confirms that these proposals capture actual lesion locations rather than other grade-correlated regions (optic disc, vessel arcs, artifacts). Without this validation, the method is best understood as a CAM-guided attention mechanism that helps grading—not as one that generates genuine lesion-level surrogates. This significantly weakens the framing in the abstract, contributions, and conclusion about "micro-lesion sensitivity" and "substantially reducing annotation needs" (in the lesion-guidance sense).

- **Ablation of GALP confounds auxiliary classification loss with proposal selection.** "w/o GALP" simultaneously removes both the auxiliary focal loss and the proposal mechanism. These serve distinct functions: the auxiliary loss strengthens intermediate feature discriminability, while the Top-K proposal selection focuses attention on high-evidence regions. A decoupled ablation—auxiliary loss only (no proposal selection), random region selection (no CAM guidance), and full GALP—would isolate which component drives the gains. Without this, attributing improvement to "lesion proposals" rather than to the well-known benefits of deep supervision is speculative.

- **CAM-based localization is poorly suited to the paper's stated motivation of recovering "small, low-contrast lesions."** The introduction explicitly frames the problem as end-to-end pipelines compressing spatial detail so that "microaneurysms" receive insufficient attention. However, CAMs are well-known to produce coarse, low-resolution localization maps that struggle precisely with small, dispersed features. The paper acknowledges that spatial partitioning uses q×q patches (q=7 or 8), which at intermediate feature map resolutions yields regions much larger than microaneurysms. The disconnect between motivation and mechanism is not addressed, and the multi-stage design does not obviously resolve this fundamental limitation.

- **Missing backbone-matched baseline clouds attribution of gains.** The authors use Swin-B pretrained on ImageNet/EyePACS, while most end-to-end baselines use earlier CNN architectures (ResNet, VGG, Inception). The strongest "apples-to-apples" comparison is LFMVDR(w/o lesion) at 80.4%, but even there it's unclear whether LFMVDR was trained with the same backbone and pretraining. Without a Swin-B multiview baseline with a simple fusion head trained identically, it is difficult to attribute the headline 83.9% to GALP+LGRF rather than to backbone capacity. The internal ablations (Table 4) confirm component benefits within the proposed architecture, but do not replace comparison against an equally strong baseline without the proposed modules.

- **No statistical significance or variance reporting despite modest absolute gains.** Key claimed improvements are 0.4–1.3% in accuracy over the strongest baselines (e.g., 83.9% vs. 82.6% CVSA; 76.0% vs. 75.6% CrossFiT). No standard deviations, confidence intervals, or repeated-run results are provided. Given the stochastic nature of training on datasets of this size (~8.6k and ~3.1k eyes), these margins could be within random variation. In the medical imaging community, reporting uncertainty is increasingly expected (as noted in reviews of comparable MoE medical imaging papers like M4oE).

### Minor:

- **The cyclic adjacent-view fusion design is under-motivated and untested.** For 4-view MFIDDR, each view only fuses with one neighbor (cyclically), not all others. No ablation compares this against all-pairs fusion or a learned view-pair selection, so it is unclear whether this restriction is principled or merely convenient.

- **No computational cost analysis.** The method adds auxiliary classifiers at multiple stages, an MoE expert pool, routing networks, and multi-stage cross-view attention. FLOPs, parameter counts, and inference time compared to baselines are absent, making it difficult to assess whether the improvements justify the added complexity (especially given the modest ~1.6% ablation gain).

- **The "with lesion" variant is under-specified.** Lesion segments are "fused with the original images via SPADE" but the exact integration (which layers, how masks are encoded, mask quality relative to SMVDR/LFMVDR) is not detailed. This weakens the SOTA-with-lesion claim, though it is tangential to the paper's main contribution.

### Trivial:

- Training dynamics of CAM-based proposals during early training (when auxiliary classifiers are inaccurate) are not discussed; this could affect convergence but may be self-correcting as training progresses.

## Nice-to-Haves

- **GEM/lesion-proposal overlay visualizations alongside ground-truth lesion maps** — this would directly test the "lesion proposal" claim and is the single most impactful addition the authors could make.
- **Error analysis for underperforming grades** (Grade 1 F1=69.7%, Grade 4 F1=36.0% w/o lesion) to reveal whether failures stem from proposal quality, class imbalance, or fusion limitations.
- **Expert specialization analysis** — what different routing experts learn, whether they specialize by lesion type or view configuration.
- **Sensitivity analysis for λ_aux and λ_load** to understand robustness to training hyperparameters.

## Removed Points

These points are flagged to be removed, treat them with caution:

- *"Method still relies on DR grade labels per eye, which are themselves costly."* — This is scope creep. The paper explicitly positions itself as reducing annotation needs *relative to methods that additionally require lesion/vessel/OD annotations*. The DR grade labels are common to all compared methods, so this does not differentiate the approach.

- *"Potential information loss from aggressive downsampling to 224×224."* — The paper follows the standard preprocessing of prior SOTA work on MFIDDR (CVSA also uses 224×224). The 512×512 resolution on DRTiD also follows CrossFiT. This is not a methodological flaw but a domain convention.

- *"No evaluation on other medical imaging tasks or ophthalmic datasets."* — The paper is specifically about multi-view DR grading, and this is an established subfield. Demanding evaluation on other tasks is scope creep.

- *"Incremental component novelty — auxiliary classifiers, CAMs, MoE, cross-attention are all established."* — Novelty of combination and application domain is a legitimate contribution form. Criticizing individual components for being established ignores the paper's actual contribution claim (the specific architecture for this problem setting).

- *"The 'with lesion' vs. 'w/o lesion' gap (0.7%) undermines the core claim."* — A 0.7% gap actually shows self-derived proposals get quite close to real lesion annotations (which is impressive), and the paper does not claim perfect equivalence. The core claim is *reducing* annotation dependency, not *eliminating* all performance gaps.

- *"No analysis of proposal behavior on Grade 0 images."* — This is an interesting question but not a weakness that undermines the paper's claims. Grade 0 images would have no discriminative lesion regions by definition; whether the model still produces "proposals" is more about CAM behavior than the paper's design.

## Novel Insights

The observation that CAM-derived proposals in this framework function more as a "grade-discriminative attention mechanism" than as genuine "lesion proposals" is a meaningful distinction. If the proposals highlight optic discs, vessel arcs, or other grade-correlated structures rather than actual microaneurysms/hemorrhages/exudates, the method is still effective for grading but its interpretability and clinical-trustworthiness claims would need to be re-examined. This distinction—between "regions that help predict the grade" and "regions that contain lesions"—is underappreciated in the CAM-as-proposal literature generally.

## Suggestions

1. **Validate proposal quality quantitatively** using MFIDDR's available lesion segmentation masks (IoU, recall at fixed proposal count between GALP proposals and ground-truth lesions). This is the single most impactful experiment to substantiate the paper's core framing.
2. **Run decoupled ablations**: (a) auxiliary loss only (no proposal selection); (b) random region selection (no CAM guidance) to isolate whether CAM-based proposals specifically help; (c) a simple CAM-weighted attention baseline without MoE routing to establish the necessity of the full pipeline.
3. **Add a backbone-matched Swin-B multiview baseline** with a simple fusion head to control for backbone capacity effects.
4. **Report standard deviations over multiple runs** or at minimum discuss the statistical reliability of reported gains.
5. **Soften the "lesion proposal" and "micro-lesion sensitivity" claims** in the abstract and conclusion to more accurately reflect what is demonstrated (CAM-based attention for grading) versus what is asserted but unverified (lesion-level localization).

## Score and Decision

**Calibration comparisons:**
- **M4oE** (MoE for multi-modal medical imaging, Accept Poster, scores 5-6): Similar MoE architecture for medical diagnosis, also faced statistical significance concerns but had thorough modality analysis and expert specialization analysis. Our paper is below M4oE due to weaker experimental controls (no backbone-matched baselines, no expert specialization analysis, no proposal quality validation).
- **CoinGAN** (weakly supervised lesion segmentation, Reject, scores 3-5): Also used weakly supervised signals for lesion guidance but was rejected for unclear novelty and poor presentation. Our paper is clearly above CoinGAN due to stronger empirical results, clearer motivation, better presentation, and the practically important finding of matching annotation-based methods.
- **DR-MoE** (dynamic routing MoE, Reject, scores 1-3): Poor novelty and unconvincing motivation. Our paper is well above this due to genuine domain contribution and solid ablations.
- **MONICA** (medical benchmark, Reject, scores 5-8): Highlighted importance of uncertainty reporting in medical imaging—relevant to our paper's weakness.

This paper makes a genuine contribution in showing that self-generated attention maps can substitute for costly annotations in multi-view DR grading, with results that are practical and well-motivated. However, the overclaiming on "lesion proposals" without validation, the confounded ablation, the missing backbone-matched comparison, and the lack of uncertainty reporting meaningfully weaken the evidential support for the headline claims. The paper would be substantially stronger with proposal-quality validation and more controlled ablations.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>